Biden’s Co-Pay Cap Is Silver Lining For Pharma In Drug Pricing Campaign

President Biden’s call to expand the US Medicare price negotiation program is naturally making headlines from his campaign-year State of the Union Address. But his call for a national cap on co-pays could be an important opportunity for industry in the years to come.

Biden with a black background
• Source: Shutterstock

“We finally beat Big Pharma.”

That line, from President Joe Biden’s State of the Union Address on 7 March, is a stark reminder that the brand name pharmaceutical industry remains squarely on the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access